Pipeline
Life sciences are radically improving the chances of treatment, even for diseases that have yet to find therapeutic answers. Thanks to new knowledge of biotechnology, ever-increasing computing power and the advancement of artificial intelligence, we will be able to respond to patients' needs even faster.
Clinical Pipeline
With our research and development pipeline, we target some of the highest-needing therapeutic areas.
| Area and Molecule | Indication | |
|---|---|---|
| Ophthalmology - NGF | Neurotrophic Keratitis | |
| Ophthalmology - NGF new formulation | Undisclosed corneal indication | |
| Ophthalmology - NGF | Glaucoma | |
| Ophthalmology - TRPLM2 inhibitor | AKC (Atopic keratoconjunctivitis) | |
| Ophthalmology - Ladarixin | Undisclosed indication | |
| CNS - NGF | Undisclosed indication | |
| Respiratory - Reparixin | CAP (Community Aquired Pneumonia) | |
| Respiratory - Reparixin | ARDS (Acute respiratory distress syndrome ) | |
| Immunology - Ladarixin | Type 1 Diabetes |
Ophthalmology - NGF
Indication: Neurotrophic Keratitis
Project Status:
Ophthalmology - NGF new formulation
Indication: Undisclosed corneal indication
Project Status:
Ophthalmology - NGF
Indication: Glaucoma
Project Status:
Ophthalmology - TRPLM2
inhibitor
Indication: AKC (Atopic keratoconjunctivitis)
Project Status:
Ophthalmology - Ladarixin
Indication: Undisclosed indication
Project Status:
CNS - NGF
Indication: Undisclosed indication
Project Status:
Respiratory - Reparixin
Indication: CAP
(Community Aquired Pneumonia)
Project Status:
Respiratory - Reparixin
Indication: ARDS (Acute respiratory distress syndrome )
Project Status:
Immunology - Ladarixin
Indication: Type 1 Diabetes
Project Status:
Latest Publications
Physiochemical Characterization of Lipidic Nanoformulations Encapsulating the Antifungal Drug Natamycin
20/04/2024
Authors: Luigi Talarico, Ilaria Clemente, Alessandro Gennari, Giulia Gabbricci, Simone Pepi, Gemma Leone, Claudia Bonechi, Claudio Rossi, Simone Luca Mattioli, Nicola Detta and Agnese Magnani
Published in:
Nanomaterials Enabling performance portability on the LiGen drug discovery pipeline
16/04/2024
Authors: Luigi Crisci a, Lorenzo Carpentieri, Biagio Cosenza, Gianmarco Accordi, Davide Gadioli, Emanuele Vitali, Gianluca Palermo, Andrea Rosario Beccari
Published in:
Future Generation Computer SystemsUnlocking performance portability on LUMI-G supercomputer: A virtual screening case study
08/04/2024
Authors: Gianmarco Accordi, Davide Gadioli, Gianluca Palermo, Luigi Crisci, Lorenzo Carpentieri, Biagio Cosenza, Andrea R. Beccari
Published in:
ACM Digital Library)
"We must always return to basic science with fresh new eyes."
Marcello Allegretti,
Chief Scientific Officer